Clinical Trials Browser

Phase 2/3 × Non-Muscle Invasive Bladder Neoplasms × Interferon-alpha × Clear all

NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms